サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1217186

創薬における人工知能（AI）の世界市場レポート2023年

Artificial Intelligence (AI) In Drug Discovery Global Market Opportunities And Strategies To 2032
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 340 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
創薬における人工知能（AI）の世界市場レポート2023年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 340 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

世界の創薬における人工知能（AI）市場は、2022年の10億4000万米ドルから2023年には13億8000万米ドルに、年平均成長率（CAGR）31.9％で成長すると予想されます。ロシア・ウクライナ戦争は、少なくとも短期的にはCOVID-19の大流行からの世界経済の回復の可能性を混乱させました。この2国間の戦争は、複数の国への経済制裁、商品価格の高騰、サプライチェーンの混乱につながり、商品やサービス全体にインフレを引き起こし、世界中の多くの市場に影響を与えています。創薬における人工知能（AI）市場は、2027年にCAGR28.4％で37億4000万米ドルに成長すると予想されています。

2022年の創薬における人工知能（AI）市場では、北米が最大の地域となっています。西欧は、創薬における人工知能（AI）市場で2番目に大きな地域でした。創薬における人工知能（AI）市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 創薬における人工知能（AI）市場の特徴

第3章 創薬における人工知能（AI）市場の動向と戦略

第4章 創薬における人工知能（AI）市場- マクロ経済シナリオ

第5章 創薬における人工知能（AI）市場の規模と成長

  • 世界市場実績、2017-2022
    • 市場の促進要因
    • 市場の抑制要因
  • 世界市場予測、2022-2027F、2032F
    • 市場の促進要因
    • 市場の抑制要因

第6章 創薬における人工知能（AI）市場セグメンテーション

  • 世界の創薬における人工知能（AI）市場、技術別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • ディープラーニング
  • 機械学習
  • 世界の創薬における人工知能（AI）市場、薬剤タイプ別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 低分子
  • 大きな分子
  • 世界の創薬における人工知能（AI）市場、治療タイプ別のセグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 代謝性疾患
  • 循環器疾患
  • 腫瘍学
  • 神経変性疾患
  • その他の治療法
  • 世界の創薬における人工知能（AI）市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 製薬会社
  • バイオ医薬品企業
  • 学術調査機関
  • その他のエンドユーザー

第7章 創薬における人工知能（AI）市場の地域および国の分析

  • 世界の創薬における人工知能（AI）市場、地域別、実績と予測、2017-2022、2022-2027F、2032F
  • 世界の創薬における人工知能（AI）市場、国別、実績と予測、2017-2022、2022-2027F、2032F

第8章 アジア太平洋の創薬における人工知能（AI）市場

  • 市場概要
  • 地域情報, COVID-19の影響,市場情報,背景情報,政府のイニシアチブ,規制,規制機関,主要団体,課税される税,法人税構造,投資,主要企業
  • 創薬における人工知能（AI）市場、技術別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 創薬における人工知能（AI）市場、薬剤タイプ別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第9章 中国の創薬における人工知能（AI）市場

  • 市場概要
  • 創薬における人工知能（AI）市場、技術別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 創薬における人工知能（AI）市場、薬剤タイプ別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第10章インドの創薬における人工知能（AI）市場

  • 創薬における人工知能（AI）市場、技術別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 創薬における人工知能（AI）市場、薬剤タイプ別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第11章 日本の創薬における人工知能（AI）市場

  • 創薬における人工知能（AI）市場、技術別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 創薬における人工知能（AI）市場、薬剤タイプ別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第12章 オーストラリアの創薬における人工知能（AI）市場

  • 創薬における人工知能（AI）市場、技術別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 創薬における人工知能（AI）市場、薬剤タイプ別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第13章 インドネシアの創薬における人工知能（AI）市場

  • 創薬における人工知能（AI）市場、技術別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 創薬における人工知能（AI）市場、薬剤タイプ別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第14章 創薬市場における韓国の創薬における人工知能（AI）市場

  • 創薬における人工知能（AI）市場、技術別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 創薬における人工知能（AI）市場、薬剤タイプ別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第15章 西欧の創薬における人工知能（AI）市場

  • 市場概要
  • 創薬における人工知能（AI）市場、技術別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 創薬における人工知能（AI）市場、薬剤タイプ別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第16章 英国の創薬における人工知能（AI）市場

  • 創薬における人工知能（AI）市場、技術別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 創薬における人工知能（AI）市場、薬剤タイプ別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第17章 ドイツの創薬における人工知能（AI）市場

  • 創薬における人工知能（AI）市場、技術別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 創薬における人工知能（AI）市場、薬剤タイプ別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第18章 フランスの創薬における人工知能（AI）市場

  • 創薬における人工知能（AI）市場、技術別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 創薬における人工知能（AI）市場、薬剤タイプ別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第19章東欧の創薬における人工知能（AI）市場

  • 市場概要
  • 創薬における人工知能（AI）市場、技術別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 創薬における人工知能（AI）市場、薬剤タイプ別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第20章 ロシアの創薬における人工知能（AI）市場

  • 創薬における人工知能（AI）市場、技術別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 創薬における人工知能（AI）市場、薬剤タイプ別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第21章 創薬市場における北米の創薬における人工知能（AI）市場

  • 市場概要
  • 創薬における人工知能（AI）市場、技術別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 創薬における人工知能（AI）市場、薬剤タイプ別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第22章 米国の創薬における人工知能（AI）市場

  • 市場概要
  • 創薬における人工知能（AI）市場、技術別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 創薬における人工知能（AI）市場、薬剤タイプ別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第23章 南米の創薬における人工知能（AI）市場

  • 市場概要
  • 創薬における人工知能（AI）市場、技術別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 創薬における人工知能（AI）市場、薬剤タイプ別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第24章 ブラジルの創薬における人工知能（AI）市場

  • 創薬における人工知能（AI）市場、技術別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 創薬における人工知能（AI）市場、薬剤タイプ別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第25章 中東の創薬における人工知能（AI）市場

  • 市場概要
  • 創薬における人工知能（AI）市場、技術別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 創薬における人工知能（AI）市場、薬剤タイプ別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第26章 アフリカの創薬における人工知能（AI）市場

  • 市場概要
  • 創薬における人工知能（AI）市場、技術別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 創薬における人工知能（AI）市場、薬剤タイプ別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第27章 創薬における人工知能（AI）市場の競合情勢と企業プロファイル

  • 創薬における人工知能（AI）市場の競合情勢
  • 創薬における人工知能（AI）市場企業プロファイル
    • IBM Corporation
    • Microsoft
    • Atomwise Inc.
    • Deep Genomics
    • Cloud Pharmaceuticals

第28章 創薬市場の人工知能（AI）における主要な合併と買収

第29章 創薬における人工知能（AI）市場の将来の見通しと潜在的な分析

第30章 付録

目次
Product Code: o&s826

“Artificial Intelligence (AI) In Drug Discovery Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial intelligence (ai) in drug discovery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence (ai) in drug discovery ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The artificial intelligence (ai) in drug discovery market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Technology: Deep Learning; Machine Learning
  • 2) By Drug Type: Small Molecule; Large Molecules
  • 3) By Therapeutic Type: Metabolic Disease; Cardiovascular Disease; Oncology; Neurodegenerative Diseases; Other Therapeutics
  • 4) By End-Users: Pharmaceutical Companies; Biopharmaceutical Companies; Academic And Research Institutes; Other End-Users
  • Companies Mentioned: IBM Corporation; Microsoft; Atomwise Inc.; Deep Genomics; Cloud Pharmaceuticals
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the artificial intelligence (AI) in drug discovery market are: IBM Corporation, Microsoft, Atomwise Inc., Deep Genomics, Cloud Pharmaceuticals, Insilico Medicine, Benevolent AI, Exscientia, Cyclica and BIOAGE.

The global artificial intelligence (ai) in drug discovery market will grow from $1.04 billion in 2022 to $1.38 billion in 2023 at a compound annual growth rate (CAGR) of 31.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services effecting many markets across the globe. The artificial intelligence (ai) in drug discovery market is expected to grow to $3.74 billion in 2027 at a CAGR of 28.4%.

The artificial intelligence (AI) in drug discovery market includes revenues earned by entities by offering AI for drug discovery. Artificial Intelligence (AI) for drug discovery is a technology that uses a simulation of the human intelligence process by machines to tackle complex problems in the drug discovery process. It helps to find new molecules to identify drug targets and develop personalized medicines in the pharmaceutical industry. Values in this market are: 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Artificial intelligence (AI) is a simulation of the human intelligence in machines that are programmed to think and behave like humans. AI helps to complete the job quickly and with relatively few errors.

North America was the largest region in the artificial intelligence (AI) in drug discovery market in 2022. Western Europe was the second largest region in the artificial intelligence (AI) in drug discovery market. The regions covered in the artificial intelligence (AI) in drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main technologies in artificial intelligence (AI) in drug discovery are deep learning and machine learning. Deep learning is a machine learning and artificial intelligence (AI) technique that mimics how humans acquire knowledge. Data science, which covers statistics and predictive modelling, incorporates deep learning as a key component. The different drug types include small molecule, large molecules and involves various types of therapies such as c, others. It is implemented in several end-users including pharmaceutical companies, biopharmaceutical companies, academic and research institutes, others.

The rise in demand for a reduction in the overall time taken for the drug discovery process is a key driver propelling the growth of the artificial intelligence (AI) in drug discovery market. Traditionally, it takes three to five years for animal models to identify and optimize molecules before they are evaluated in humans whereas start-ups based on AI have been identifying and designing new drugs in a matter of few days or months. For instance, in 2020, the British start-up Exscientia and Japan's Sumitomo Dainippon Pharma have used artificial intelligence to produce an obsessive-compulsive disorder (OCD) medication, decreasing the development time from four years to less than one year. The reduction in overall time taken for the drug discovery process drives the artificial intelligence (AI) in drug discovery market's growth.

The shortage of skilled professionals is expected to hamper the AI in drug discovery market. The employees have to re-train or learn new skill sets to work efficiently on the complex AI machines to get the desired results for the drug. The shortage of skills acts as a major hindrance to drug discovery through AI, discouraging companies to adopt AI-based machines for drug discovery. in 2020, according to a study by National Skills Coalition, one-third of America's workers lacked digital skills. This figure accounted for 18% of workers with only a few skills and 13% with no digital abilities.

Major companies operating in the AI drug delivery market are adopting strategic collaborations to research and discover drugs using AI and are gaining significant popularity in the artificial intelligence in drug discovery market. For instance, in August 2022, Atomwise, a US-based artificial intelligence systems company, partnered with Sanofi. The partnership aimed at computationally identifying and investigating up to five pharmacological targets using the Atomwise AI-powered AtomNet technology. To find, create, and advance lead compounds for up to five Sanofi-exclusive targets, Atomwise received a $20 million upfront payment from Sanofi. Sanofi is a French pharmaceutical and healthcare company.

In July 2020, Curi Bio, a leading developer of human iPSC-based platforms for drug discovery, acquired Dana Solutions for an undisclosed amount. This acquisition will give Curi Bio access to Dana's AI/ML platforms for modelling cell and tissue phenotype, automated platform for contractility analysis of beating cardiomyocyte and platform for predictive safety pharmacology. Dana Solutions is a leading AI solutions provider for the life sciences industry.

The countries covered in the artificial intelligence (AI) in drug discovery market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from goods and/or services sold within the specified market and geography through sales, grants, or donations in terms of currency (in USD ($) unless otherwise specified).

The revenues for a specified geography are consumption values - that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced. It does not include revenues from resales either further along the supply chain or as part of other products.

The artificial intelligence (AI) in drug discovery market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI) in drug discovery market statistics, including artificial intelligence (AI) in drug discovery industry global market size, regional shares, competitors with a artificial intelligence (AI) in drug discovery market share, detailed artificial intelligence (AI) in drug discovery market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI) in drug discovery industry. This artificial intelligence (AI) in drug discovery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Table of Contents

1. Executive Summary

2. Table Of Contents

3. List Of Figures

4. List Of Tables

5. Report Structure

6. Introduction And Market Characteristics

  • 6.1. General Market Definition
  • 6.2. Summary
  • 6.3. Artificial Intelligence (AI) In Drug Discovery Market Definition And Segmentations
  • 6.4. Market Segmentation By Technology
    • 6.4.1. Context-Aware Processing
    • 6.4.2. Natural Language Processing
    • 6.4.3. Querying Method
    • 6.4.4. Deep Learning
  • 6.5. Market Segmentation By Drug Type
    • 6.5.1. Small Molecules
    • 6.5.2. Large Molecules
  • 6.6. Market Segmentation By Therapeutic Type
    • 6.6.1. Metabolic Diseases
    • 6.6.2. Cardiovascular Disease
    • 6.6.3. Oncology
    • 6.6.4. Neurodegenerative Diseases
    • 6.6.5. Respiratory Diseases
    • 6.6.6. Anti-Infective Diseases
    • 6.6.7. Other Therapeutics
  • 6.7. Market Segmentation By End-User
    • 6.7.1. Pharmaceutical Companies
    • 6.7.2. Biopharmaceutical Companies
    • 6.7.3. Academic And Research Institutes
    • 6.7.4. Other End-Users

7. Major Market Trends

  • 7.1. Integration of Multi-Omics Data
  • 7.2. Increasing Investments
  • 7.3. Use Of AI In Drug Screening
  • 7.4. Use Of AI In Target Selection
  • 7.5. Introduction Of AI Innovation Labs
  • 7.6. Partnerships And Collaborations

8. Global Market Size And Growth

  • 8.1. Market Size
  • 8.2. Historic Market Growth, 2017 - 2022, Value ($ Million)
    • 8.2.1. Market Drivers 2017 - 2022
    • 8.2.2. Market Restraints 2017 - 2022
  • 8.3. Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
    • 8.3.1. Market Drivers 2022 - 2027
    • 8.3.2. Market Restraints 2022 - 2027

9. Global Artificial Intelligence (AI) In Drug Discovery Market Segmentation

  • 9.1. Global Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 9.2. Global Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 9.3. Global Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 9.4. Global Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)

10. Artificial Intelligence (AI) In Drug Discovery Market, Regional and Country Analysis

  • 10.1. Global Artificial Intelligence (AI) In Drug Discovery Market, By Region, Historic and Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 10.2. Global Artificial Intelligence (AI) In Drug Discovery Market, By Country, Historic and Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)

11. Asia-Pacific Market

  • 11.1. Summary
  • 11.2. Market Overview
    • 11.2.1. Region Information
    • 11.2.2. Market Information
    • 11.2.3. Background Information
    • 11.2.4. Government Initiatives
    • 11.2.5. Regulations
    • 11.2.6. Regulatory Bodies
    • 11.2.7. Major Associations
    • 11.2.8. Taxes Levied
    • 11.2.9. Corporate Tax Structure
    • 11.2.10. Investments
    • 11.2.11. Major Companies
  • 11.3. Asia-Pacific Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
  • 11.4. Asia-Pacific Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
  • 11.5. Asia-Pacific Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 11.6. Asia-Pacific Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 11.7. Asia-Pacific Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 11.8. Asia-Pacific Artificial Intelligence (AI) In Drug Discovery Market: Country Analysis
  • 11.9. China Market
  • 11.10. Summary
  • 11.11. Market Overview
    • 11.11.1. Country Information
    • 11.11.2. Market Information
    • 11.11.3. Background Information
    • 11.11.4. Government Initiatives
    • 11.11.5. Regulations
    • 11.11.6. Regulatory Bodies
    • 11.11.7. Major Associations
    • 11.11.8. Taxes Levied
    • 11.11.9. Corporate Tax Structure
    • 11.11.10. Investments
    • 11.11.11. Major Companies
  • 11.12. China Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
  • 11.13. China Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
  • 11.14. China Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 11.15. China Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 11.16. China Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 11.17. India Market
  • 11.18. India Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
  • 11.19. India Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
  • 11.20. India Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 11.21. India Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 11.22. India Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 11.23. Japan Market
  • 11.24. Japan Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
  • 11.25. Japan Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
  • 11.26. Japan Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 11.27. Japan Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 11.28. Japan Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 11.29. Australia Market
  • 11.30. Australia Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
  • 11.31. Australia Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
  • 11.32. Australia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 11.33. Australia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 11.34. Australia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 11.35. Indonesia Market
  • 11.36. Indonesia Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
  • 11.37. Indonesia Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
  • 11.38. Indonesia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 11.39. Indonesia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 11.40. Indonesia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 11.41. South Korea Market
  • 11.42. South Korea Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
  • 11.43. South Korea Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
  • 11.44. South Korea Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 11.45. South Korea Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 11.46. South Korea Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)

12. Western Europe Market

  • 12.1. Summary
  • 12.2. Market Overview
    • 12.2.1. Region Information
    • 12.2.2. Market Information
    • 12.2.3. Background Information
    • 12.2.4. Government Initiatives
    • 12.2.5. Regulations
    • 12.2.6. Regulatory Bodies
    • 12.2.7. Major Associations
    • 12.2.8. Taxes Levied
    • 12.2.9. Corporate Tax Structure
    • 12.2.10. Investments
    • 12.2.11. Major Companies
  • 12.3. Western Europe Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
  • 12.4. Western Europe Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
  • 12.5. Western Europe Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 12.6. Western Europe Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 12.7. Western Europe Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 12.8. Western Europe Artificial Intelligence (AI) In Drug Discovery Market: Country Analysis
  • 12.9. UK Market
  • 12.10. UK Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
  • 12.11. UK Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
  • 12.12. UK Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 12.13. UK Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 12.14. UK Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 12.15. Germany Market
  • 12.16. Germany Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
  • 12.17. Germany Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
  • 12.18. Germany Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 12.19. Germany Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 12.20. Germany Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 12.21. France Market
  • 12.22. France Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
  • 12.23. France Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
  • 12.24. France Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 12.25. France Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 12.26. France Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)

13. Eastern Europe Market

  • 13.1. Summary
  • 13.2. Market Overview
    • 13.2.1. Region Information
    • 13.2.2. Market Information
    • 13.2.3. Background Information
    • 13.2.4. Government Initiatives
    • 13.2.5. Regulations
    • 13.2.6. Regulatory Bodies
    • 13.2.7. Major Associations
    • 13.2.8. Taxes Levied
    • 13.2.9. Corporate Tax Structure
    • 13.2.10. Investments
    • 13.2.11. Major Companies
  • 13.3. Eastern Europe Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
  • 13.4. Eastern Europe Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
  • 13.5. Eastern Europe Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 13.6. Eastern Europe Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 13.7. Eastern Europe Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 13.8. Eastern Europe Artificial Intelligence (AI) In Drug Discovery Market: Country Analysis
  • 13.9. Russia Market
  • 13.10. Russia Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
  • 13.11. Russia Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
  • 13.12. Russia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 13.13. Russia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 13.14. Russia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)

14. North America Market

  • 14.1. Summary
  • 14.2. Market Overview
    • 14.2.1. Region Information
    • 14.2.2. Market Information
    • 14.2.3. Background Information
    • 14.2.4. Government Initiatives
    • 14.2.5. Regulations
    • 14.2.6. Regulatory Bodies
    • 14.2.7. Major Associations
    • 14.2.8. Taxes Levied
    • 14.2.9. Corporate Tax Structure
    • 14.2.10. Investments
    • 14.2.11. Major Companies
  • 14.3. North America Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
  • 14.4. North America Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
  • 14.5. North America Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 14.6. North America Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 14.7. North America Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 14.8. North America Artificial Intelligence (AI) In Drug Discovery Market: Country Analysis
  • 14.9. USA Market
  • 14.10. Summary
  • 14.11. Market Overview
    • 14.11.1. Country Information
    • 14.11.2. Market Information
    • 14.11.3. Background Information
    • 14.11.4. Government Initiatives
    • 14.11.5. Regulations
    • 14.11.6. Regulatory Bodies
    • 14.11.7. Major Associations
    • 14.11.8. Taxes Levied
    • 14.11.9. Corporate Tax Structure
    • 14.11.10. Investments
    • 14.11.11. Major Companies
  • 14.12. USA Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
  • 14.13. USA Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
  • 14.14. USA Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 14.15. USA Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 14.16. USA Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)

15. South America Market

  • 15.1. Summary
  • 15.2. Market Overview
    • 15.2.1. Region Information
    • 15.2.2. Market Information
    • 15.2.3. Background Information
    • 15.2.4. Government Initiatives
    • 15.2.5. Regulations
    • 15.2.6. Regulatory Bodies
    • 15.2.7. Major Associations
    • 15.2.8. Taxes And Duties
    • 15.2.9. Corporate Tax Structure
    • 15.2.10. Investments
    • 15.2.11. Major Companies
  • 15.3. South America Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
  • 15.4. South America Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
  • 15.5. South America Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 15.6. South America Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 15.7. South America Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 15.8. South America Artificial Intelligence (AI) In Drug Discovery Market: Country Analysis
  • 15.9. Brazil Market
  • 15.10. Brazil Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
  • 15.11. Brazil Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
  • 15.12. Brazil Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 15.13. Brazil Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 15.14. Brazil Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)

16. Middle East Market

  • 16.1. Summary
  • 16.2. Market Overview
    • 16.2.1. Region Information
    • 16.2.2. Market Information
    • 16.2.3. Background Information
    • 16.2.4. Government Initiatives
    • 16.2.5. Regulations
    • 16.2.6. Regulatory Bodies
    • 16.2.7. Major Associations
    • 16.2.8. Taxes Levied
    • 16.2.9. Corporate Tax Structure
    • 16.2.10. Investments
    • 16.2.11. Major Companies
  • 16.3. Middle East Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
  • 16.4. Middle East Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
  • 16.5. Middle East Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 16.6. Middle East Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 16.7. Middle East Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)

17. Africa Market

  • 17.1. Summary
  • 17.2. Market Overview
    • 17.2.1. Region Information
    • 17.2.2. Market Information
    • 17.2.3. Background Information
    • 17.2.4. Government Initiatives
    • 17.2.5. Regulations
    • 17.2.6. Regulatory Bodies
    • 17.2.7. Major Associations
    • 17.2.8. Taxes Levied
    • 17.2.9. Corporate Tax Structure
    • 17.2.10. Investments
    • 17.2.11. Major Companies
  • 17.3. Africa Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
  • 17.4. Africa Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
  • 17.5. Africa Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 17.6. Africa Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 17.7. Africa Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)

18. Competitive Landscape And Company Profiles

  • 18.1. Company Profiles
  • 18.2. IBM Corporation
    • 18.2.1. Company Overview
    • 18.2.2. Products And Services
    • 18.2.3. Business Strategy
    • 18.2.4. Financial Overview
  • 18.3. Microsoft Corporation
    • 18.3.1. Company Overview
    • 18.3.2. Products And Services
    • 18.3.3. Business Strategy
    • 18.3.4. Financial Overview
  • 18.4. NVIDIA Corporation
    • 18.4.1. Company Overview
    • 18.4.2. Products And Services
    • 18.4.3. Business Strategy
    • 18.4.4. Financial Overview
  • 18.5. Exscientia plc
    • 18.5.1. Company Overview
    • 18.5.2. Products And Services
    • 18.5.3. Business Strategy
    • 18.5.4. Financial Overview
  • 18.6. Alphabet Inc
    • 18.6.1. Company Overview
    • 18.6.2. Products And Services
    • 18.6.3. Business Strategy
    • 18.6.4. Financial Overview

19. Key Mergers And Acquisitions

  • 19.1. Recursion Pharmaceuticals Acquired Cyclica And Valence
  • 19.2. BioNTech Acquired InstaDeep
  • 19.3. Verseon Corporation Acquired Edammo
  • 19.4. iBio Acquired Rubryc Therapeutics
  • 19.5. Odyssey Therapeutics Acquired Rahko
  • 19.6. Genentech Acquired Prescient Design
  • 19.7. X-Chem Acquired Glamorous AI
  • 19.8. Exscientia Acquired Austrian Company Allcyte
  • 19.9. Relay Therapeutics Acquired ZebiAI

20. Opportunities And Strategies

  • 20.1. Global Artificial Intelligence (AI) In Drug Discovery Market In 2027 - Countries Offering Most New Opportunities
  • 20.2. Global Artificial Intelligence (AI) In Drug Discovery Market In 2027 - Segments Offering Most New Opportunities
  • 20.3. Global Artificial Intelligence (AI) In Drug Discovery Market In 2027 - Growth Strategies
    • 20.3.1. Market Trend Based Strategies
    • 20.3.2. Competitor Strategies

21. Artificial Intelligence (AI) In Drug Discovery Market, Conclusions And Recommendations

  • 21.1. Conclusions
  • 21.2. Recommendations
    • 21.2.1. Product
    • 21.2.2. Place
    • 21.2.3. Price
    • 21.2.4. Promotion
    • 21.2.5. People

22. Appendix

  • 22.1. Market Data Sources
  • 22.2. Research Methodology
  • 22.3. Currencies
  • 22.4. The Business Research Company
  • 22.5. Copyright and Disclaimer